BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6752167)

  • 1. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT; Kovacs K; Horvath E; Thorner MO
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology of prolactin cell adenomas of the human pituitary.
    Horvath E; Kovacs K
    Semin Diagn Pathol; 1986 Feb; 3(1):4-17. PubMed ID: 3303229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
    Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
    Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
    Nissim M; Ambrosi B; Bernasconi V; Giannattasio G; Giovanelli MA; Bassetti M; Vaccari U; Moriondo P; Spada A; Travaglini P; Faglia G
    J Endocrinol Invest; 1982; 5(6):409-15. PubMed ID: 7169515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regression with purely medical treatment of pituitary prolactin adenomas].
    Bricaire H
    Ann Med Interne (Paris); 1982; 133(1):58. PubMed ID: 7065591
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O; Niwa J; Inoue Y; Akagawa S; Kobayashi K
    No Shinkei Geka; 1983 Jan; 11(1):51-60. PubMed ID: 6682184
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
    Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
    Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of prolactin-producing pituitary adenomas].
    von Werder K; Fahlbusch R; Rjosk HK
    Dtsch Med Wochenschr; 1982 Jun; 107(23):887-9. PubMed ID: 7200861
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolactin adenoma with ophthalmological manifestations. Treatment with bromocriptine].
    Saraux H; Offret H; Brasnu C; Charpentier G
    Bull Soc Ophtalmol Fr; 1980; 80(6-7):489-93. PubMed ID: 7408092
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine treatment of prolactinomas.
    von Werder K; Eversmann T; Fahlbusch R; Rjosk HK
    N Engl J Med; 1979 Jun; 300(24):1391-2. PubMed ID: 440368
    [No Abstract]   [Full Text] [Related]  

  • 19. Bromocriptine treatment of prolactinomas.
    Bergh T; Nillius SJ; Lundberg PO; Wide L
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440367
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine treatment of prolactinomas.
    Aronoff SL; Daughaday WH; Laws ER
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.